|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10,341.00 GBX | -0.20% |
|
-0.12% | -1.53% |
| 08:26am | PRESS DIGEST-British Business - April 24 | RE |
| 23/04 | AstraZeneca CEO says Europe must invest more to protect its 'health sovereignty' | RE |
| Capitalization | 21TCr 19TCr 18TCr 16TCr 30TCr 18,21800Cr 33TCr 2,05500Cr 80TCr 8,16900Cr 80TCr 78TCr 30,36500Cr | P/E ratio 2025 * |
22.8x | P/E ratio 2026 * | 18.5x |
|---|---|---|---|---|---|
| Enterprise value | 23TCr 21TCr 19TCr 18TCr 32TCr 19,96200Cr 37TCr 2,25100Cr 88TCr 8,95100Cr 88TCr 86TCr 33,27200Cr | EV / Sales 2025 * |
4.07x | EV / Sales 2026 * | 3.71x |
| Free-Float |
96.62% | Yield 2025 * |
2.36% | Yield 2026 * | 2.46% |
More valuation ratios
* Estimated data
More news
Last Transcript: AstraZeneca PLC
More recommendations
More press releases
More news
| 1 day | -0.25% | ||
| 1 week | -0.12% | ||
| Current month | -8.41% | ||
| 1 month | -11.20% | ||
| 3 months | -6.74% | ||
| 6 months | -13.60% | ||
| Current year | -1.53% |
| 1 week | 10,048 |  | 10,358.2 |
| 1 month | 9,573.5 | | 11,632 |
| Current year | 9,573.5 | | 12,208 |
| 1 year | 9,573.5 | | 13,388 |
| 3 years | 9,399 | | 13,388 |
| 5 years | 6,736 | | 13,388 |
| 10 years | 3,680 | | 13,388 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 64 | 01/10/2012 |
Aradhana Sarin
DFI | Director of Finance/CFO | 51 | 01/08/2021 |
| Chief Tech/Sci/R&D Officer | 61 | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 69 | 06/04/1999 | |
Pascal Soriot
BRD | Director/Board Member | 64 | 01/10/2012 |
Philip Broadley
BRD | Director/Board Member | 64 | 27/04/2017 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 8.29% | 57 M€ | +7.20% | - | |
| 5.39% | 200 M€ | -10.39% | - | |
| 5.17% | 21 M€ | -8.73% | - | |
| 4.89% | 1,138 M€ | -4.18% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.20% | -0.12% | -8.38% | -1.87% | 21TCr | ||
| +0.23% | +9.95% | +13.41% | +186.39% | 74TCr | ||
| -1.50% | +0.66% | +4.20% | -15.26% | 37TCr | ||
| +1.88% | -1.14% | +5.46% | +11.69% | 31TCr | ||
| -0.81% | -7.38% | -53.88% | +4.73% | 28TCr | ||
| +0.19% | +2.50% | +14.26% | -29.57% | 25TCr | ||
| +0.73% | +3.07% | +4.69% | +6.05% | 21TCr | ||
| -0.29% | -0.54% | -37.97% | -8.69% | 20TCr | ||
| -0.18% | -5.45% | +2.20% | +8.78% | 15TCr | ||
| +0.82% | -0.11% | +58.89% | +66.87% | 13TCr | ||
| Average | +0.27% | +2.15% | +0.29% | +22.91% | 28.63TCr | |
| Weighted average by Cap. | +0.28% | +4.18% | +0.61% | +48.90% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.74TCr 5.05TCr 4.74TCr 4.32TCr 7.97TCr 4,90300Cr 9TCr 55TCr 22TCr 2,19900Cr 22TCr 21TCr 8,17200Cr | 6.09TCr 5.36TCr 5.03TCr 4.59TCr 8.45TCr 5,20300Cr 9.55TCr 59TCr 23TCr 2,33300Cr 23TCr 22TCr 8,67200Cr |
| Net income | 936.04Cr 823.44Cr 772.55Cr 704.72Cr 1.3TCr 80TCr 1.47TCr 9.01TCr 3.52TCr 36TCr 3.51TCr 3.44TCr 1,33200Cr | 1.16TCr 1.02TCr 957.38Cr 873.31Cr 1.61TCr 99TCr 1.82TCr 11TCr 4.36TCr 44TCr 4.35TCr 4.26TCr 1,65000Cr |
| Net Debt | 2.04TCr 1.8TCr 1.69TCr 1.54TCr 2.83TCr 1,74400Cr 3.2TCr 20TCr 7.69TCr 78TCr 7.66TCr 7.5TCr 2,90700Cr | 1.27TCr 1.12TCr 1.05TCr 956.81Cr 1.76TCr 1,08500Cr 1.99TCr 12TCr 4.78TCr 49TCr 4.77TCr 4.67TCr 1,80800Cr |
More financial data
* Estimated data
Employees
94,300
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/25/24 | 10,318.52 p | -0.42% | 2,06,990 |
| 23/25/23 | 10,362.00 p | +2.19% | 41,99,351 |
| 22/25/22 | 10,140.00 p | +0.16% | 23,55,705 |
| 17/25/17 | 10,124.00 p | -1.27% | 32,70,916 |
| 16/25/16 | 10,254.00 p | -0.25% | 19,01,968 |
Delayed Quote London S.E., April 24, 2025 at 03:00 pm IST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
137.63USD
Average target price
180.17USD
Spread / Average Target
+30.91%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AZN Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition